{"nct_id":"NCT01593254","title":"Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib","status":"COMPLETED","status_verified_date":"2023-05","start_date":"2012-09-12","start_date_type":"ACTUAL","primary_completion_date":"2017-11-08","primary_completion_date_type":"ACTUAL","completion_date":"2022-04-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}